Skip to content
DataLookout
Menu

NCT07381036

Nebulized Ketamine Versus Nebulized Magnesium Sulfate Versus Placebo for the Prevention of Postoperative Sore Throat .

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words Show 6 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Primary completion pushed from Jul 1, 2026 to Dec 1, 2026
    • Final enrollment: 171 participants (planned 150)
    • Study completion pushed from Sep 1, 2026 to Dec 30, 2026
    • Study sites: 0 to 1
    • Study title expanded, about 1 word
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

To compare the incidence of Post operative sore throat method.
Timeframe: 24 hours

Arms and interventions

Ketamine groupExperimental
Mg sulfate groupExperimental
Placebo groupPlacebo comparator

Drugs: Ketamine nebulizer, Mg sulfate nebulizer, Placebo

Sites

1 site in 1 country

  • Sohag University HospitalSohag, Sohag Governorate, Egypt